Clinical trials
Phase 4 Diabetes Insipidus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 6 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of North Carolina, Chapel Hill | 2 |
| Antonios Likourezos | 1 |
| Azienda Usl di Bologna | 1 |
| Brigham and Women's Hospital | 1 |
| Cairo University | 1 |
| Finn Gustafsson | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Hospital Nossa Senhora da Conceicao | 1 |
| Intermountain Health Care, Inc. | 1 |
| Konkuk University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Insipidus | 25 |
| Hemorrhage | 7 |
| Shock, Septic | 7 |
| Blood Loss, Surgical | 4 |
| Heart Failure | 3 |
| Shock | 3 |
| Sepsis | 2 |
| Ascites | 1 |
| Atrial Fibrillation | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.